SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells

Yu Jiang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yucheng Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Clinical Epigenetics
March 5, 2020
10.1186/s13148-020-00833-5
Cited by 12

Related Papers

Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial
|EClinicalMedicine|2023|61
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps
|JAMA|2025|23
An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trial
|Nature Communications|2025|5
[Expert consensus on the prevention and treatment of adverse reactions in subcutaneous immunotherapy(2023, Chongqing)].
|PubMed|2023|3
Exploring the adverse effects of 1,3,6,8-tetrabromo-9H-carbazole in atherosclerotic model mice by metabolomic profiling integrated with mechanism studies in vitro
|Chemosphere|2023|2